best glp 1 providers The GLP-1 Programs in 2026 for Women Over 40 Ideal for those on prescription GLP Featured GLP-1 Program 2026 |
Description
On average, patients return to their pre-treatment weight within 1.7 years of stopping any weight management medication, including semaglutide and tirzepatide

doi: 10.1136/jim-2017-000445 48 WilliamsDMNawazAEvansM

The last search was performed in July 2022
Fen-phen was associated with life-threatening hypertension and heart valve issues

Well, if you look carefully, it doesnt really show any benefit to semaglutide either